Other studies have also demonstrated strong correlations of increased RBP4 levels with carotid IMT and components of the metabolic syndrome including hypertension, hypertriglyceridemia, and waist circumference, suggesting that RBP4 may serve as a marker of metabolic complications and atherosclerosis (22, 23, 106). This evidence concerns the gene RBP4 and metabolic syndrome.